Natixis Advisors LLC reduced its holdings in CME Group Inc. by 11.4%, ending the first quarter with 162,144 shares valued at approximately $43 million. CME Group reported earnings of $2.96 per share, exceeding analysts' expectations of $2.91, with a revenue of $1.69 billion for the quarter. The company declared a quarterly dividend of $1.25 per share, representing an annualized dividend of $5.00 and a yield of 1.8%. Other institutional investors also recently modified their holdings of the company. SeaCrest Wealth Management LLC increased its stake in shares of CME Group by 3.0% in the 1st quarter. New Age Alpha Advisors LLC increased its stake in CME Group by 50.0% during the 4th quarter. OneAscent Financial Services LLC lifted its stake in shares of CME Group by 4.0% in the first quarter. Ballentine Partners LLC lifted its stake in shares of CME Group by 0.8% in the first quarter. Wealthcare Advisory Partners LLC grew its holdings in shares of CME Group by 3.6% during the first quarter. 87.75% of the stock is currently owned by institutional investors. CME Group Price Performance opened at $278.28 on Friday. The company has a market cap of $100.28 billion, a price-to-earnings ratio of 26.94, a PEG ratio of 4.93 and a beta of 0.44. The firm's fifty day moving average is $276.14 and its 200 day moving average is $263.55. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12. CME Group Inc. has a 52-week low of $193.25 and a 52-week high of $290.79. CME Group last released its quarterly earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.91 by $0.05. The company had revenue of $1.69 billion for the quarter, compared to the consensus estimate of $1.68 billion. CME Group had a net margin of 58.48% and a return on equity of 14.60%. CME Group's revenue was up 10.4% on a year-over-year basis. During the same quarter in the prior year, the firm earned $2.56 earnings per share. Sell-side analysts forecast that CME Group Inc. will post 10.49 EPS for the current fiscal year. CME Group Dividend Announcement The company also recently disclosed a quarterly dividend, which was paid on Wednesday, June 25th. Shareholders of record on Monday, June 9th were given a dividend of $1.25 per share. The ex-dividend date was Monday, June 9th. This represents a $5.00 dividend on an annualized basis and a yield of 1.8%. CME Group's payout ratio is 48.40%. Insider Buying and Selling at CME Group In other news, insider sold 4,650 shares of the company's stock in a transaction dated Monday, May 5th. The shares were sold at an average price of $280.61, for a total value of $1,304,836.50. Following the transaction, the insider directly owned 8,336 shares in the company, valued at approximately $2,339,164.96. This represents a 35.81% decrease in their ownership of the stock. Director Charles P. Carey sold 3,000 shares of the company's stock in a transaction dated Thursday, May 15th. The stock was sold at an average price of $272.56, for a total transaction of $817,680.00. Following the completion of the transaction, the director owned 5,400 shares in the company, valued at approximately $1,471,824. The trade was a 35.71% decrease in their ownership of the stock. Over the last three months, insiders have sold 10,400 shares of company stock valued at $2,881,130. Insiders own 0.30% of the company's stock. Wall Street Analysts Forecast Growth CME has been the topic of several analyst reports. Piper Sandler lifted their price target on shares of CME Group from $283.00 to $296.00 and gave the stock an 'overweight' rating in a research note on Tuesday, July 15th. UBS Group restated a 'neutral' rating and set a $305.00 target price on shares of CME Group in a research report on Thursday, July 24th. Citigroup boosted their target price on shares of CME Group from $265.00 to $275.00 and gave the company a 'neutral' rating in a research report on Thursday, July 3rd. Barclays set a $298.00 target price on shares of CME Group and gave the company an 'equal weight' rating in a research report on Thursday, July 24th. Four equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating and four have issued a buy rating to the company's stock. According to data from MarketBeat.com, the stock has a consensus rating of 'Hold' and an average target price of $261.93. CME Group Company Profile CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Natixis Advisors LLC Reduces Holdings in CME Group Inc. (NASDAQ:CME)

Natixis Advisors LLC reduced its holdings in CME Group Inc. by 11.4%, ending Q1 with 162,144 shares valued at $43 million. CME Group reported $2.96 EPS, exceeding analyst expectations, with $1.69 billion revenue. The company declared a $1.25 quarterly dividend, representing a 1.8% yield. Other institutional investors adjusted their stakes, while insiders sold shares. Analysts updated price targets, with Piper Sandler raising its rating to 'overweight' and UBS setting a $305 target. CME Group has a $100.28 billion market cap, 26.94 P/E ratio, and 10.4% YoY revenue growth.